[Federal Register Volume 85, Number 145 (Tuesday, July 28, 2020)]
[Page 45445]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-16290]



Advisory Committee on the Medical Uses of Isotopes: Meeting 

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.


SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a 
meeting of the Advisory Committee on the Medical Uses of Isotopes 
(ACMUI) on September 21-22, 2020. A sample of agenda items to be 
discussed during the public session includes: A discussion of the 
ACMUI's review and analysis of medical events from fiscal year 2019; a 
discussion of the ACMUI's review and analysis of non-medical events 
from fiscal year 2019; a discussion on the U.S. Food and Drug 
Administration's regulatory process for the development of drugs and 
devices; an update on the NRC's Phase 2 revision of Regulatory Guide 
8.39, ``Release of Patients Administered Radioactive Material''; and an 
update on the activities of the NRC's Medical Radiation Safety Team. 
The agenda is subject to change. The current agenda and any updates 
will be available on the ACMUI's Meetings and Related Documents web 
page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html or by emailing Ms. Kellee Jamerson at the contact information 
    Purpose: Discuss issues related to 10 CFR part 35 Medical Use of 
Byproduct Material.
    Date and Time for Open Sessions: September 21, 2020, from 10 a.m. 
to 2 p.m. and September 22, 2020, from 12:15 p.m. to 1:45 p.m. Eastern 
Standard Time (EST).

                   Date                          Webinar information
September 21, 2020........................  Link: https://usnrc.webex.com.
                                            Event number: 199 744 7681.
September 22, 2020........................  Link: https://usnrc.webex.com.
                                            Event number: 199 319 2198.

    Date and Time for Closed Session: September 22, 2020, from 10 a.m. 
to 12 p.m. EST. This session will be closed to conduct the ACMUI's 
required annual training.
    Public Participation: The meeting will be held as a webinar using 
the WebEx meeting platform. Any member of the public who wishes to 
participate in any open sessions of this meeting should register in 
advance of the meeting by visiting the link and entering the event 
number(s) provided above. Upon successful registration, a confirmation 
email will be generated providing the telephone bridge line and a link 
to join the webinar on the day of the meeting. Members of the public 
should also monitor the NRC's Public Meeting Schedule at https://www.nrc.gov/pmns/mtg for any meeting updates. If there are any 
questions regarding the meeting, persons should contact Ms. Jamerson 
using the information below.
    Contact Information: Ms. Kellee Jamerson, email: 
[email protected], telephone: 301-415-7408.

Conduct of the Meeting

    Darlene F. Metter, M.D. will chair the meeting. Dr. Metter will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Jamerson using the contact information listed 
above. All submittals must be received by the close of business on 
September 15, 2020, three business days before the meeting, and must 
pertain to the topics on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html on or about November 6, 2020.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Jamerson of their planned 
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in title 
10 of the Code of Federal Regulations, Part 7.

    Dated at Rockville, Maryland, this 23rd day of July, 2020.

    For the U.S. Nuclear Regulatory Commission.

Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2020-16290 Filed 7-27-20; 8:45 am]